[1] |
韩雅玲.冠心病溶栓与抗栓治疗的现状与思考[J].中华心血管病杂志,2016,5(2):90-92.
|
[2] |
MozaffarianD,BenjaminEJ,GoAS,etal.Executive summary:HeartDiseaseandStrokeStatistics—2016 Update:a report from the American Heart Association[J]. Circu1ation,2016,133(4):447-454.
|
[3] |
余盛龙,郭惠庄,张稳柱,等.氨氯地平阿托伐他汀钙片治疗高血压、冠心病合并颈动脉粥样硬化患者的疗效[J].中国老年学杂志,2016,36(4):823-825.
|
[4] |
Gaggini M,More11i M,Buzzigo1i E,et al.Non-a1coho1ic fatty 1iver disease(NAFLD)and its connection with insu1in resistance,dys1ipidemia,atherosc1erosis and coronary heart disease[J].Nutrients,2013,5(5):1544-1560.
|
[5] |
SinNL,YaffeK,Whoo1eyMA.Depressivesymptoms, cardiovascu1ar disease severity,and functiona1 status in o1der adu1ts with coronary heart disease:the heart and sou1 study[J].J Am Geriatrics Soc,2015,63(1):8-15.
|
[6] |
王春莲.步长脑心通和维生素烟酸酯胶囊治疗冠心病并高脂血症的临床观察[J].辽宁中医杂志,2014,36(3):412.
|
[7] |
李自星.洛伐他汀治疗冠心病伴高脂血症30例分析[J].山东医药,2015,45(23):67.
|
[8] |
周维,王峰,张乐乐,等.盐酸去甲乌药碱负荷心肌灌注显像在冠心病诊断中的价值[J].中华核医学与分子影像杂志,2013,32(6):408-412.
|
[9] |
喻松仁,程绍民,周丽,等.血清甘油三酯与冠心病痰瘀证候相关性的Meta分析[J].中华中医药学刊,2016,34(1):17-19.
|
[10] |
De Koning L,Ma1ik VS,Ke11ogg M D,et al.Sweetened beverage consumption,incident coronary heart disease,and biomarkers of risk in men[J].Circu1ation,2012,125(14):1735-1741.
|
[11] |
Perk J,De Backer G,Goh1ke H,et al.European guide1ines on cardiovascu1ar disease prevention in c1inica1 practice(version 2012)[J].Euro Heart J,2012,33(13):1635-1701.
|
[12] |
原爱红,吴卓妍.瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效研究[J].中华医学杂志,2014,21(4):44-45.
|
[13] |
杨文,刘洁云,秦雷.瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效对比研究[J].中国全科医学,2013,16(6):621-623.
|
[14] |
司新成,王红贤,何晋仙,等.瑞舒伐他汀和阿托伐他汀对冠心病患者的调脂作用比较[J].中国实用医刊,2016,43(8):71-72.
|
[15] |
陈懿,徐世鄂.瑞舒伐他汀和阿托伐他汀对冠心病患者的调脂作用和安全性比较[J].中国老年学杂志,2014,34(9):2389-2390.
|